CBIO Catalyst Biosciences Inc

Price (delayed)

$4.33

Market cap

$135.74M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.36

Enterprise value

$54.18M

Highlights
The company's equity rose by 37% QoQ and by 7% YoY
Catalyst Biosciences's debt has decreased by 12% YoY and by 10% QoQ
CBIO's quick ratio has surged by 64% since the previous quarter but it is down by 15% year-on-year
CBIO's EPS is down by 15% since the previous quarter but it is up by 7% year-on-year
CBIO's gross margin has dropped by 103% since the previous quarter and by 103% year-on-year
CBIO's gross profit has dropped by 101% since the previous quarter and by 101% year-on-year

Key stats

What are the main financial stats of CBIO
Market
Shares outstanding
31.35M
Market cap
$135.74M
Enterprise value
$54.18M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.3
Price to sales (P/S)
20.32
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.96
Earnings
Revenue
$6.05M
EBIT
-$74.63M
EBITDA
-$74.47M
Free cash flow
-$74.86M
Per share
EPS
-$3.36
Free cash flow per share
-$2.64
Book value per share
$3.32
Revenue per share
$0.21
TBVPS
$4.19
Balance sheet
Total assets
$119.08M
Total liabilities
$14.99M
Debt
$1.48M
Equity
$104.09M
Working capital
$102.34M
Liquidity
Debt to equity
0.01
Current ratio
8.22
Quick ratio
7.62
Net debt/EBITDA
1.1
Margins
EBITDA margin
-1,231.1%
Gross margin
-1.9%
Net margin
-1,233.7%
Operating margin
-1,235.6%
Efficiency
Return on assets
-66.4%
Return on equity
-77.9%
Return on invested capital
-152.7%
Return on capital employed
-71.1%
Return on sales
-1,233.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CBIO stock price

How has the Catalyst Biosciences stock price performed over time
Intraday
1.17%
1 week
-4.84%
1 month
3.59%
1 year
-44.98%
YTD
-31.38%
QTD
-14.09%

Financial performance

How have Catalyst Biosciences's revenue and profit performed over time
Revenue
$6.05M
Gross profit
-$115,000
Operating income
-$74.74M
Net income
-$74.63M
Gross margin
-1.9%
Net margin
-1,233.7%
CBIO's gross margin has dropped by 103% since the previous quarter and by 103% year-on-year
CBIO's gross profit has dropped by 101% since the previous quarter and by 101% year-on-year
CBIO's revenue has dropped by 71% since the previous quarter and by 63% year-on-year
The net income has plunged by 69% YoY and by 33% from the previous quarter

Growth

What is Catalyst Biosciences's growth rate over time

Valuation

What is Catalyst Biosciences stock price valuation
P/E
N/A
P/B
1.3
P/S
20.32
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.96
CBIO's EPS is down by 15% since the previous quarter but it is up by 7% year-on-year
The company's equity rose by 37% QoQ and by 7% YoY
CBIO's P/B is 30% above its 5-year quarterly average of 1.0
The stock's price to sales (P/S) is 101% more than its last 4 quarters average of 10.1
CBIO's revenue has dropped by 71% since the previous quarter and by 63% year-on-year

Efficiency

How efficient is Catalyst Biosciences business performance
CBIO's ROIC has plunged by 96% YoY and by 37% from the previous quarter
Catalyst Biosciences's ROA has plunged by 51% YoY and by 30% from the previous quarter
The ROE has dropped by 50% year-on-year and by 30% since the previous quarter

Dividends

What is CBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CBIO.

Financial health

How did Catalyst Biosciences financials performed over time
CBIO's quick ratio has surged by 64% since the previous quarter but it is down by 15% year-on-year
CBIO's current ratio has surged by 63% since the previous quarter but it is down by 10% year-on-year
Catalyst Biosciences's debt is 99% lower than its equity
Catalyst Biosciences's debt to equity has shrunk by 50% QoQ and by 50% YoY
The company's equity rose by 37% QoQ and by 7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.